These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2420184)

  • 1. The pathogenesis of hyaline arteriolosclerosis.
    Gamble CN
    Am J Pathol; 1986 Mar; 122(3):410-20. PubMed ID: 2420184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation.
    Hill GS; Heudes D; Bariéty J
    Kidney Int; 2003 Mar; 63(3):1027-36. PubMed ID: 12631084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative immunohistochemical study of splenic arterial hyalinosis in health and disease.
    Gupta RK; Schuster R; Christian WD
    Am J Pathol; 1972 Oct; 69(1):79-88. PubMed ID: 4117028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaline arteriolar nephrosclerosis. Immunofluorescence findings in the vascular lesions.
    Valenzuela R; Gogate PA; Deodhar SD; Gifford RW
    Lab Invest; 1980 Dec; 43(6):530-4. PubMed ID: 7003256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of red splenic arteriolar hyaline with rapid death: a clinicopathological study of 82 autopsy cases.
    Kotani H; Miyao M; Manabe S; Ishida T; Kawai C; Abiru H; Tamaki K
    Diagn Pathol; 2012 Dec; 7():182. PubMed ID: 23276152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus.
    Goldblatt F; Yuste J; Isenberg DA; Rahman A; Brown J
    Rheumatology (Oxford); 2009 Dec; 48(12):1498-501. PubMed ID: 19797312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of complement by human vascular endothelial cells: effects of hypoxia/reoxygenation and IL-1beta activation.
    Haun JB; Baldwin WM; Alevriadou BR
    Transpl Int; 2005 Apr; 18(4):475-82. PubMed ID: 15773971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b.
    DiLillo DJ; Pawluczkowycz AW; Peng W; Kennedy AD; Beum PV; Lindorfer MA; Taylor RP
    Mol Immunol; 2006 Mar; 43(7):1010-9. PubMed ID: 15961157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement system becomes activated by the classical pathway in intracranial aneurysm walls.
    Tulamo R; Frösen J; Junnikkala S; Paetau A; Kangasniemi M; Peláez J; Hernesniemi J; Niemelä M; Meri S
    Lab Invest; 2010 Feb; 90(2):168-79. PubMed ID: 19997064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte-bound complement components in health and disease.
    Garratty G
    Prog Clin Biol Res; 1980; 43():133-55. PubMed ID: 6999500
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
    Mehta RL; Takahashi H; Rudick RA; Knutson DW
    J Immunol; 1986 Mar; 136(5):1765-71. PubMed ID: 2936811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    Pangburn MK; Morrison DC; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1980 Feb; 124(2):977-82. PubMed ID: 7356723
    [No Abstract]   [Full Text] [Related]  

  • 18. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.
    Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS
    Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of protein co-localization on B cells opsonized with rituximab and complement using the ImageStream multispectral imaging flow cytometer.
    Beum PV; Lindorfer MA; Hall BE; George TC; Frost K; Morrissey PJ; Taylor RP
    J Immunol Methods; 2006 Dec; 317(1-2):90-9. PubMed ID: 17067631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK; Holme E; Hamilton E; Whaley K
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.